Atorvastatin Reduces Plasma Levels of Chemokine (CXCL10) in Patients with Crohn's Disease

Olof Grip, Sabina Janciauskiene · 2009

Read Atorvastatin Reduces Plasma Levels of Chemokine (CXCL10) in Patients with Crohn's Disease by Olof Grip, Sabina Janciauskiene (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0005263.txt.

Description

In Crohn's disease, the gut is inflamed, and certain chemokines, signals that call in immune cells, run high. One of them, CXCL10, tracks with disease activity. Grip and Janciauskiene tested in PLOS ONE in 2009 whether a statin drug could lower it.

Statins are cholesterol drugs that also calm chemokine production in heart patients. Patients with Crohn's disease who took atorvastatin showed reduced plasma levels of CXCL10, as the title states. The result hints that a familiar heart drug might also help soothe gut inflammation. A cheap pill used for years in heart care would be easy to test in gut clinics, since its side effects and safe dose are already well known.

Catalog record

CREATOROlof Grip, Sabina Janciauskiene
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE30 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005263

Browse the full library · About the Tower of Babel